the hsf national new investigator (nni) award provides salary support to individuals who have clearly demonstrated excellence during their doctoral and post-doctoral training in cardiovascular or cerebrovascular research.

new investigator awards are tenable in canada only.

please note:

• the foundation will be offering as part of the gia and national new investigator (nni) program funding specifically targeted towards the improvement of the heart health for women.  applicants applying for this opportunity will also be considered in the regular pool of gia and/or nni applications.  guidelines for application are identical to the gia and/or nni except where otherwise indicated.  please note, all other gia and nni guidelines and requirements apply (e.g. maximum number of applications eligible for submission).
• all applicants (irrespective of proposal focus) to the gia and nni programs are required to include a sex and gender-based analysis in their research design (or provide rationale as to why it would not be relevant to their project).

deadline: september 12, 2016.

guidelines and application form for the national new investigator award competition.

frequently asked questions

the specific objective of this funding opportunity is to:

• create new knowledge in reproductive, child and maternal health and cancer through the analysis of existing canadian data.

this funding opportunity is to support research projects with an aim to improve the social inclusion of people living with dementia (neurodegenerative diseases including alzheimer disease) and their carers in communities at local, regional, national and international levels.

the specific objectives of this funding opportunity are to support research projects focused on:

• improving the social inclusion of those living with dementia and/or their carers – “living better with dementia”; and
• identifying and evaluating scalable relevant interventions having an impact on social inclusion at the individual or population levels (policies, programs, etc.).

the aims of the health services and health economics research innovation grants are to fund novel/innovative approaches to improving service delivery across the cancer control continuum.

the specific objectives of this funding opportunity are:

• conduct intervention research that tests innovative models of care delivery along the cancer control continuum.
• create/improve on a decision making framework for health care policy makers that incorporates evidence of effective and cost-effective models of care, is based on public and patient engagement, and is relevant to health care policy makers.
• standardize processes and procedures to improve safety and access to chemotherapy, with a special focus on oral chemotherapy.
• standardize and validate metrics to measure quality and safety of cancer care, from different perspectives (i.e., patients/public, providers, policy makers).
• develop a data linkage research platform - that includes administrative health data, clinical data from electronic medical records, cancer registry data, clinical trials data, and tumour banks - both within and across provinces.
• advance and apply implementation science to improve quality of cancer care including how new technologies are used and communicated to patients.

relevant research areas

the cihr institute of cancer will provide funding for applications that are determined to be relevant to the following research areas:

• disease management across the cancer control continuum (from prevention to palliation);
• development of mechanisms for timely adoption and implementation of research findings;
• investigation and development of solutions to overcome barriers to data access to integrate cancer health services delivery;
• system sustainability through divestment (i.e., choosing wisely) and its promotion;
• research that examines vulnerable/underserved populations (first nations, official language minorities, etc.). the icr’s strategic plan includes the following:
  • aboriginal peoples, individuals from low socio-economic backgrounds, individuals in rural communities and new immigrants;
  • those impacted by poverty, lack of access to care, cultural issues, linguistics etc. that make them vulnerable.

biofuelnet canada has just launched three new calls for proposals in the following areas related to the development of advanced biofuels: social outreach, techno-economic analysis and novel approaches. each is being funded for 22,500$ for the period of 2016-2107.

click here to apply or to see all the details: http://portal.biofuelnet.ca/docs/applications_cycle_1

deadline to apply: sept. 1st, 2016 at 20:00 est

who can apply? this call for proposals is open to anyone meeting the eligibility criteria of nserc or sshrc. there is no requirement for the applicant to have already participated in biofuelnet.

questions? contact xiaomin zhou at xiaomin.zhou@mcgill.ca

the prevalence of neurodegenerative diseases of aging is high and growing rapidly.  the rapid response program was created to catalyze and jumpstart the development of safe and effective treatments for these diseases. the program provides short-term grants as seed funding for novel, high-risk, high-reward translational research projects that advance the development of therapeutics for neurodegenerative diseases of aging. proposed projects may relate to any disease; however, the basis for selection will be on the potential impact of the project on neurodegenerative diseases of aging.

important dates

round 3: ad-related diseases (ad, ftd, mci and prodromes)

information session: august 10th, 2016 1:00 pm edt
loi deadline:  september 12th, 2016 2:00 pm edt

please note that a new request for proposal for the provision of contract research, by immigration, refugees and citizenship canada (ircc), on the issue of immigration in canada’s official language minority communities (olmcs), was posted on this website: https://buyandsell.gc.ca/procurement-data/tender-notice/pw-16-00741475

you will find a description of all seven research projects in appendix “d”, statement of work (p. 26). the research projects must address one of the following seven themes:

theme i : participation of french-speaking immigrants in a minority situation

theme ii : settlement and integration experiences of french-speaking immigrants and refugees from sub-saharan africa

theme iii : a study on french-speaking refugees in winnipeg and saint boniface

theme iv : access to employment among recent french-speaking immigrants in the atlantic region

theme v : the community learning centre (clc) initiative” and english-speaking immigrants and refugees in quebec: a case study

theme vi : re-settlement and integration experiences of english-speaking refugees in quebec

theme vii : access to employment among recent english-speaking immigrants in quebec

the deadline for submitting a bid is september 16,2016 (14h00 eastern daylight time)

overview

founded in 2015, biocanrx (biotherapeutics for cancer treatment) is a not-for-profit organization with a mission to improve outcomes for cancer patients by accelerating the development of cost-effective and curative biotherapies. biocanrx was awarded seed funding of $25 million from the federal government’s networks of centres of excellence (nce) program, and has attracted additional tens of millions from partners in all sectors of the economy.

biocanrx supports biotherapeutic development research through four research programs and a number of core facilities that are accessible to all members of the biocanrx network. three of the research programs (catalyst projects, enabling studies, clinical trials) are designed to reflect the translational focus of biocanrx, which organizes its investments into a pipeline-like structure common to the biotechnology industry. the fourth program (clinical, social, and economic impact program) funds research into issues of scientific methodology, clinical trial design, patient engagement, health economics and commercial viability of biocanrx biotherapeutic platforms and technologies. all research programs are targeted toward applicants who have already made substantial advances in their basic research programs and are now ready to work in collaborative, multidisciplinary, academic–industry teams to move their discoveries into the clinic in a rational, scientifically well-supported and highly disciplined fashion. 

apply when you are ready

biocanrx is using a rolling, open call that allows research teams to submit proposals to any of our research programs at any time.

for details about each of our funding programs, please visit our research program page.

for an overview of the application and review process, please visit our application process.

our next submission deadline is november 9, 2016.